• Explore /
  • Poster
  • / CCTG HN.10: A phase II single-arm trial of elective volume adjusted de-escalation radiotherapy (EVADER) in patients with low-risk HPV-related oropharyngeal squamous cell carcinoma (NCT03822897).

CCTG HN.10: A phase II single-arm trial of elective volume adjusted de-escalation radiotherapy (EVADER) in patients with low-risk HPV-related oropharyngeal squamous cell carcinoma (NCT03822897).

Abstract Poster

Authors

null

Scott Victor Bratman

Department of Radiation Oncology, Princess Margaret Cancer Centre, Toronto, ON, Canada

Scott Victor Bratman , Eric Berthelet , James B. Butler , John R de Almeida , Irene Karam , Ur Metser , Robert Anton Olson , Craig Pochini , John Waldron , Eugene Yu , Andrea McNiven , Winson Y. Cheung , Marc Gaudet , Sarah Hunter , Bingshu E. Chen , Wendy R. Parulekar

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Session

Session Title

Head and Neck Cancer

Track

Head and Neck Cancer

Sub Track

Advanced/Metastatic Disease

Clinical Trial Registration Number

NCT03822897

Citation

J Clin Oncol 38: 2020 (suppl; abstr TPS6592)

DOI

10.1200/JCO.2020.38.15_suppl.TPS6592

Abstract #

TPS6592

Poster Bd #

253

Abstract Disclosures

Similar Posters

First Author: Heath Devin Skinner

First Author: Bhishamjit S. Chera

First Author: Jesse Meir Zaretsky

First Author: Krzysztof Misiukiewicz